SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-21-024935
Filing Date
2021-05-06
Accepted
2021-05-06 16:02:32
Documents
14
Period of Report
2021-05-06
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K acor-8k_20210506.htm   iXBRL 8-K 33580
2 EX-99.1 acor-ex991_49.htm EX-99.1 342132
3 GRAPHIC g1bru3f2jmnm000001.jpg GRAPHIC 4764
  Complete submission text file 0001564590-21-024935.txt   526141

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA acor-20210506.xsd EX-101.SCH 5768
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE acor-20210506_lab.xml EX-101.LAB 18732
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE acor-20210506_pre.xml EX-101.PRE 11167
7 EXTRACTED XBRL INSTANCE DOCUMENT acor-8k_20210506_htm.xml XML 3419
Mailing Address 420 SAW MILL RIVER ROAD ARDSLEY NY 10502
Business Address 420 SAW MILL RIVER ROAD ARDSLEY NY 10502 914-347-4300
ACORDA THERAPEUTICS INC (Filer) CIK: 0001008848 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-31938 | Film No.: 21897604
SIC: 2836 Biological Products, (No Diagnostic Substances)